10.67
前日終値:
$10.69
開ける:
$10.7
24時間の取引高:
32,850
Relative Volume:
0.15
時価総額:
$18.38M
収益:
$8.62M
当期純損益:
$-6.15M
株価収益率:
-0.9674
EPS:
-11.03
ネットキャッシュフロー:
$-5.32M
1週間 パフォーマンス:
-0.19%
1か月 パフォーマンス:
+125.11%
6か月 パフォーマンス:
+209.02%
1年 パフォーマンス:
+137.11%
Evoke Pharma Inc Stock (EVOK) Company Profile
EVOK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
EVOK
Evoke Pharma Inc
|
10.67 | 18.41M | 8.62M | -6.15M | -5.32M | -11.03 |
|
ZTS
Zoetis Inc
|
122.06 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.30 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.87 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.21 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.82 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-06-22 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2019-03-05 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2018-03-08 | 繰り返されました | B. Riley FBR, Inc. | Buy |
| 2017-10-19 | 再開されました | FBR & Co. | Buy |
| 2017-03-16 | 繰り返されました | Rodman & Renshaw | Buy |
| 2017-01-30 | アップグレード | Laidlaw | Neutral → Buy |
| 2017-01-05 | アップグレード | Rodman & Renshaw | Neutral → Buy |
| 2016-12-23 | 繰り返されました | Rodman & Renshaw | Neutral |
| 2016-07-19 | 繰り返されました | FBR Capital | Outperform |
| 2016-07-19 | ダウングレード | Noble Financial | Buy → Hold |
| 2016-07-18 | ダウングレード | Rodman & Renshaw | Buy → Neutral |
| 2016-03-16 | 開始されました | Northland Capital | Outperform |
| 2016-03-14 | 繰り返されました | Ascendiant Capital Markets | Buy |
| 2016-02-17 | 再開されました | FBR Capital | Outperform |
| 2014-12-03 | 繰り返されました | MLV & Co | Buy |
| 2014-11-07 | 開始されました | MLV & Co | Buy |
| 2014-04-22 | 開始されました | Laidlaw | Buy |
| 2013-11-19 | 開始されました | Aegis Capital | Buy |
すべてを表示
Evoke Pharma Inc (EVOK) 最新ニュース
How Evoke Pharma Inc. stock reacts to bond yields2025 Volatility Report & Proven Capital Preservation Tips - newser.com
Why retail investors favor Evoke Pharma Inc. stockEarnings Recap Report & Real-Time Volume Triggers - newser.com
Evaluating Evoke Pharma Inc. with trendline analysisJuly 2025 Pullbacks & Proven Capital Preservation Tips - newser.com
KLEIN ROGER M Insider Trades - Nasdaq
How to read the order book for Evoke Pharma Inc.Earnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
Evoke Pharma Inc. (EVOK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Evoke Pharma Inc. stock go up soon2025 Technical Patterns & Real-Time Buy Signal Notifications - newser.com
Using economic indicators to assess Evoke Pharma Inc. potential2025 Historical Comparison & Real-Time Stock Movement Alerts - newser.com
Will Evoke Pharma Inc. stock continue dividend increasesInsider Buying & Safe Capital Allocation Plans - newser.com
What drives Evoke Pharma Inc stock priceStock Buyback Updates & Rapid Portfolio Growth - earlytimes.in
Risk vs reward if holding onto Evoke Pharma Inc.2025 Year in Review & High Accuracy Trade Alerts - newser.com
Evoke Pharma Reports Increased Sales Amid Ongoing Losses - MSN
What valuation multiples suggest for Evoke Pharma Inc. stock2025 Price Momentum & Breakout Confirmation Alerts - newser.com
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger-COMP, HFWA, EVOK, and JTAI - The Malaysian Reserve
[SC TO-T] Evoke Pharma Inc Third-Party Tender Offer | EVOK SEC FilingForm SC TO-T - Stock Titan
Evoke Pharma’s Merger Uncertainty: Potential Risks to Business Operations and Financial Health - MSN
How currency fluctuations impact Evoke Pharma Inc. stockJuly 2025 Catalysts & Low Risk Growth Stock Ideas - newser.com
Identifying reversal signals in Evoke Pharma Inc.Weekly Trade Analysis & Stock Portfolio Risk Management - newser.com
Using Bollinger Bands to evaluate Evoke Pharma Inc.2025 Trading Volume Trends & Community Verified Swing Trade Signals - newser.com
Advanced analytics toolkit walkthrough for Evoke Pharma Inc.2025 Key Highlights & Technical Pattern Alert System - newser.com
Why Evoke Pharma Inc. stock is a value investor pickPrice Action & AI Driven Stock Movement Reports - newser.com
Price action breakdown for Evoke Pharma Inc.Portfolio Growth Summary & Intraday High Probability Setup Alerts - newser.com
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger-HBAN, AVDL, EVOK, and TRUE - The Malaysian Reserve
Quantitative breakdown of Evoke Pharma Inc. recent moveMarket Risk Summary & Daily Chart Pattern Signals - newser.com
How Evoke Pharma Inc. stock responds to policy changesJuly 2025 Momentum & Accurate Trade Setup Notifications - newser.com
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger-HBAN, AVDL, EVOK, and TRUE - Benzinga
Evoke Pharma (EVOK) Achieves Significant Revenue Growth in Q3 - GuruFocus
Evoke Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025 - MarketScreener
Form SC14D9CWritten communication relating to third party tender offer - ADVFN
[8-K] Evoke Pharma Inc Reports Material Event | EVOK SEC FilingForm 8-K - Stock Titan
Evoke Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Evoke Pharma Inc (EVOK) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):